Synthesis and Characterization of Antiviral Drug Candidate Molecules Against the Respiratory Syncytial Virus

Text Registration

Synthesis and Characterization of Antiviral Drug Candidate Molecules Against the Respiratory Syncytial Virus

Status

Published

on 10 Jun 2021

Year of Creation

2021

Ali Abbas Sabi

Registration Number

TX0008989934

on 10 Jun 2021

The U.S. Copyright record (Registration Number: TX0008989934) dated 10 Jun 2021, pertains to an electronic file (eService) titled "Synthesis and Characterization of Antiviral Drug Candidate Molecules Against the Respiratory Syncytial Virus" created in 2021. The copyright holder is Ali Abbas Sabi, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Ali Abbas Sabi.

Ali Abbas Sabi

Application Details

Registration Number

TX0008989934

Registration Date

6/10/2021

Year of Creation

2021

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Ali Abbas Sabi

Notes

Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Synthesis and Characterization of Antiviral Drug Candidate Molecules Against the Respiratory Syncytial Virus

Author Statement: Ali Abbas Sabi Citizenship: not known Authorship: text

Notes

Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Synthesis and Characterization of Antiviral Drug Candidate Molecules Against the Respiratory Syncytial Virus

Author Statement: Ali Abbas Sabi Citizenship: not known Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.